Skip to content

POHMBVUMDCKQJL-YSEBNWTJSA-N

C33H33ClF5N9O3 — CID 138552423

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC[(2S)-2-[(4R)-2-amino-4-(2,2-dimethylpropyl)-4-[3-fluoro-4-(1-methylpyrazol-3-yl)phenyl]-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] N-(2,2-difluorocyclopropyl)carbamate
SMILESCn1ccc(-c2ccc([C@@]3(CC(C)(C)C)N=C(N)N([C@H](COC(=O)NC4CC4(F)F)c4ccc(Cl)c(-n5ncnc5C(F)F)c4)C3=O)cc2F)n1
InChIInChI=1S/C33H33ClF5N9O3/c1-31(2,3)15-32(18-6-7-19(21(35)12-18)22-9-10-46(4)45-22)28(49)47(29(40)44-32)24(14-51-30(50)43-25-13-33(25,38)39)17-5-8-20(34)23(11-17)48-27(26(36)37)41-16-42-48/h5-12,16,24-26H,13-15H2,1-4H3,(H2,40,44)(H,43,50)/t24-,25?,32-/m1/s1
InChIKeyPOHMBVUMDCKQJL-YSEBNWTJSA-N
MW734.13 g/mol
LogP6.06
Rot. Bonds10

About POHMBVUMDCKQJL-YSEBNWTJSA-N

POHMBVUMDCKQJL-YSEBNWTJSA-N (PubChem CID 138552423) has the molecular formula C33H33ClF5N9O3 and a molecular weight of 734.13 g/mol. Its IUPAC name is [(2S)-2-[(4R)-2-amino-4-(2,2-dimethylpropyl)-4-[3-fluoro-4-(1-methylpyrazol-3-yl)phenyl]-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] N-(2,2-difluorocyclopropyl)carbamate.

Molecular Properties

Compound NamePOHMBVUMDCKQJL-YSEBNWTJSA-N
PubChem CID138552423
Molecular FormulaC33H33ClF5N9O3
Molecular Weight734.13 g/mol
Exact Mass733.23
IUPAC Name[(2S)-2-[(4R)-2-amino-4-(2,2-dimethylpropyl)-4-[3-fluoro-4-(1-methylpyrazol-3-yl)phenyl]-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] N-(2,2-difluorocyclopropyl)carbamate
SMILESCn1ccc(-c2ccc([C@@]3(CC(C)(C)C)N=C(N)N([C@H](COC(=O)NC4CC4(F)F)c4ccc(Cl)c(-n5ncnc5C(F)F)c4)C3=O)cc2F)n1
InChIInChI=1S/C33H33ClF5N9O3/c1-31(2,3)15-32(18-6-7-19(21(35)12-18)22-9-10-46(4)45-22)28(49)47(29(40)44-32)24(14-51-30(50)43-25-13-33(25,38)39)17-5-8-20(34)23(11-17)48-27(26(36)37)41-16-42-48/h5-12,16,24-26H,13-15H2,1-4H3,(H2,40,44)(H,43,50)/t24-,25?,32-/m1/s1
InChIKeyPOHMBVUMDCKQJL-YSEBNWTJSA-N
XLogP6.06
TPSA145.55 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds10
Heavy Atoms51
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500734.13
LogP ≤ 56.06
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Analyze POHMBVUMDCKQJL-YSEBNWTJSA-N with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of POHMBVUMDCKQJL-YSEBNWTJSA-N?
The IUPAC name of POHMBVUMDCKQJL-YSEBNWTJSA-N (CID 138552423) is [(2S)-2-[(4R)-2-amino-4-(2,2-dimethylpropyl)-4-[3-fluoro-4-(1-methylpyrazol-3-yl)phenyl]-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] N-(2,2-difluorocyclopropyl)carbamate.
What is the SMILES notation for POHMBVUMDCKQJL-YSEBNWTJSA-N?
The canonical SMILES for POHMBVUMDCKQJL-YSEBNWTJSA-N is Cn1ccc(-c2ccc([C@@]3(CC(C)(C)C)N=C(N)N([C@H](COC(=O)NC4CC4(F)F)c4ccc(Cl)c(-n5ncnc5C(F)F)c4)C3=O)cc2F)n1.
What is the InChIKey of POHMBVUMDCKQJL-YSEBNWTJSA-N?
The InChIKey is POHMBVUMDCKQJL-YSEBNWTJSA-N. The full InChI is InChI=1S/C33H33ClF5N9O3/c1-31(2,3)15-32(18-6-7-19(21(35)12-18)22-9-10-46(4)45-22)28(49)47(29(40)44-32)24(14-51-30(50)43-25-13-33(25,38)39)17-5-8-20(34)23(11-17)48-27(26(36)37)41-16-42-48/h5-12,16,24-26H,13-15H2,1-4H3,(H2,40,44)(H,43,50)/t24-,25?,32-/m1/s1.
What are the key properties of POHMBVUMDCKQJL-YSEBNWTJSA-N?
POHMBVUMDCKQJL-YSEBNWTJSA-N has a molecular weight of 734.13 g/mol, XLogP of 6.06, 10 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for POHMBVUMDCKQJL-YSEBNWTJSA-N is sourced from PubChem (CID 138552423), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.